Metastatic hormone-sensitive prostate cancer Clinical Trials
Conditions / Metastatic hormone-sensitive prostate cancer
Delta Trials indexes 4 clinical trials for Metastatic hormone-sensitive prostate cancer in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 62 research sites around the world. An additional 2 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
4
Total Trials
2
Recruiting
0
Completed
2
Other Active
0
Terminated since 2020
62
Study Locations
Browse by location (62 total)
- Pontoise, France 1 trialAll trials in Pontoise, France
- Brest, France 1 trialAll trials in Brest, France
- Vienna, Austria 1 trialAll trials in Vienna, Austria
- Cornwall, United Kingdom 1 trialAll trials in Cornwall, United Kingdom
- Strasbourg, France 1 trialAll trials in Strasbourg, France
- Scunthorpe, United Kingdom 1 trialAll trials in Scunthorpe, United Kingdom
- Pátrai, Greece 1 trialAll trials in Pátrai, Greece
- Mineola, United States 1 trialAll trials in Mineola, United States
- Athens, Greece 1 trialAll trials in Athens, Greece
- Barcelona, Spain 1 trialAll trials in Barcelona, Spain
- Quint-fonsegrives, France 1 trialAll trials in Quint-fonsegrives, France
- Nîmes, France 1 trialAll trials in Nîmes, France
- New York, United States 1 trialAll trials in New York, United States
- Munster, Germany 1 trialAll trials in Munster, Germany
- Lugo, Spain 1 trialAll trials in Lugo, Spain
- La Tronche, France 1 trialAll trials in La Tronche, France
- Málaga, Spain 1 trialAll trials in Málaga, Spain
- Devon, United Kingdom 1 trialAll trials in Devon, United Kingdom
- Santiago de Compostela, Spain 1 trialAll trials in Santiago de Compostela, Spain
- A Coruña, Spain 1 trialAll trials in A Coruña, Spain